Status:
RECRUITING
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
Lead Sponsor:
The Lymphoma Academic Research Organisation
Conditions:
Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)
Eligibility:
FEMALE
18+ years
Brief Summary
Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant. Because of the low incidence of this disease and the peculiar his...
Eligibility Criteria
Inclusion
- Adult patients with an anaplastic large cell lymphoma associated with breast implants
Exclusion
- \-
Key Trial Info
Start Date :
June 7 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 7 2032
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04220970
Start Date
June 7 2017
End Date
June 7 2032
Last Update
January 14 2026
Active Locations (31)
Enter a location and click search to find clinical trials sorted by distance.
1
A. Z. Sint-Jan Brugge-Oostende AV
Bruges, Belgium
2
Clinique Universitaire Saint LUC
Brussels, Belgium
3
Cliniques Universitaires de Bruxelles - Hôpital Erasme
Brussels, Belgium
4
Institut Jules Bordet
Brussels, Belgium